Novel Product for the Management of Coronary Ruptures Happening during Percutaneous Coronary Interventions

Figure 4

(a) Spongostan package. (b) Spongostan sponge. (c) Stirring and soaking one-fifth of the sponge in contrast media. (d) Dissolving the sponge using two syringes. (e) Dissolved Spongostan in the contrast. (f) Injection through microcatheter tip.

(a)

(b)

(c)

(d)

(e)

(f)